Literature DB >> 17162367

Gene expression by PBMC in primary sclerosing cholangitis: evidence for dysregulation of immune mediated genes.

Christopher A Aoki1, Kevin Dawson, Thomas P Kenny, M Eric Gershwin, Christopher L Bowlus.   

Abstract

Primary sclerosing cholangitis (PSC) is a chronic disease of the bile ducts characterized by an inflammatory infiltrate and obliterative fibrosis. The precise role of the immune system in the pathogenesis of PSC remains unknown. We used RNA microarray analysis to identify immune-related genes and pathways that are differentially expressed in PSC. Messenger RNA (mRNA) from peripheral blood mononuclear cells (PBMC) was isolated from both patients with PSC and age and sex matched healthy controls. Samples from 5 PSC patients and 5 controls were analyzed by microarray and based upon rigorous statistical analysis of the data, relevant genes were chosen for confirmation by RT-PCR in 10 PSC patients and 10 controls. Using unsupervised hierarchical clustering, gene expression in PSC was statistically different from our control population. Interestingly, genes within the IL-2 receptor beta, IL-6 and MAP Kinase pathways were found to be differently expressed in patients with PSC compared to controls. Further, individual genes, TNF-alpha induced protein 6 (TNFaip6) and membrane-spanning 4-domains, subfamily A (ms4a) were found to be upregulated in PSC while similar to Mothers against decapentaplegic homolog 5 (SMAD 5) was downregulated. In conclusion, several immune-related pathways and genes were differentially expressed in PSC compared to control patients, giving further evidence that this disease is systemic and immune-mediated.

Entities:  

Mesh:

Year:  2006        PMID: 17162367      PMCID: PMC2270783          DOI: 10.1080/17402520600800085

Source DB:  PubMed          Journal:  Clin Dev Immunol        ISSN: 1740-2522


  5 in total

1.  Cutting edge issues in primary sclerosing cholangitis.

Authors:  Christopher L Bowlus
Journal:  Clin Rev Allergy Immunol       Date:  2011-10       Impact factor: 8.667

2.  In situ mass spectrometry of autoimmune liver diseases.

Authors:  Christopher L Bowlus; Erin H Seeley; Joanna Roder; Julia Grigorieva; Heinrich Roder; Richard M Caprioli; Meric Gershwin
Journal:  Cell Mol Immunol       Date:  2011-01-24       Impact factor: 11.530

Review 3.  Post-Transplant Disease Recurrence in Pediatric PSC.

Authors:  Nisreen Soufi; Fateh Bazerbachi; Mark Deneau
Journal:  Curr Gastroenterol Rep       Date:  2018-08-06

4.  Epigenetic Signatures Discriminate Patients With Primary Sclerosing Cholangitis and Ulcerative Colitis From Patients With Ulcerative Colitis.

Authors:  Manon de Krijger; Ishtu L Hageman; Andrew Y F Li Yim; Jan Verhoeff; Juan J Garcia Vallejo; Patricia H P van Hamersveld; Evgeni Levin; Theodorus B M Hakvoort; Manon E Wildenberg; Peter Henneman; Cyriel Y Ponsioen; Wouter J de Jonge
Journal:  Front Immunol       Date:  2022-03-16       Impact factor: 7.561

Review 5.  The immunobiology of primary sclerosing cholangitis.

Authors:  Jonathan H Aron; Christopher L Bowlus
Journal:  Semin Immunopathol       Date:  2009-05-26       Impact factor: 9.623

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.